UPCOMING MEETING
Bioethics Collaborative
The Bioethics Collaborative is a forum to propose, share, and discuss ethical challenges in multi-national clinical trials. Meetings convene individuals from academia, industry, patient/participant groups, ethics committees, government, and others.
The Bioethics Collaborative Planning Committee chooses discussion topics in advance. The MRCT Center then prepares a case statement of the topic to be discussed and circulates the case statement, relevant examples and readings prior to the meetings. At the end of each Bioethics Collaborative meeting, we consider whether the topic warrants further discussion or development as a publication or other deliverable. In order to promote open dialogue, the meetings are run by ‘Chatham House Rule,’ by which commentary will not be attributed to any individual nor to their institutional affiliation.
For any questions or interest in sponsoring the Bioethics Collaborative, contact us at mrct@bwh.harvard.edu.
Objectives
- Nurture collaboration regarding emerging bioethical issues
- Host productive, thoughtful, and enjoyable meetings
- Produce deliverables derived from Bioethics Collaborative meetings
Project leadership & Staff
- Mark Barnes, JD, LLM. Faculty Co-Director, MRCT Center
- Emina Berbic, MPH. Program Manager, MRCT Center
- Barbara E. Bierer, MD. Faculty Director, MRCT Center
- Luke Gelinas, PhD, MA. Senior Advisor, MRCT Center
- Sarah White, MPH. Executive Director, MRCT Center
- Sarah Evenson, MBE, Project Manager, MRCT Center
With appreciation to the following sponsors:
- Genentech, Inc
- Eli Lilly & Co.
- Johnson & Johnson
- Merck, known as MSD outside of U.S and Canada
- Pfizer, Inc.
- Sanofi
- Takeda Pharmaceuticals
Meetings
No Additional Results Found